Clinical Relevance of Galectin-1 in Hematologic Malignancies Treated With Non-Myeloablative Hemopoietic Stem Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases

Bone Marrow Transplantation
TransplantationHematology
2006English

Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring After Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Prognostic Impact of Lymphocyte Subpopulations in Peripheral Blood After Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Non-Myeloablative Bone Marrow Stem Cell Transplantation for MDX Mice Myodystrophy Therapy

Journal of Cell Science & Therapy
2012English

Double-Unit Cord Blood Transplantation After Myeloablative Conditioning for Patients With Hematologic Malignancies: A Multicenter Phase II Study in Japan

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy